HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fernanda F Ramos Selected Research

Recombinant Proteins

6/2022A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum.
1/2022Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection.
2/2021Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
12/2020Corrigendum to "Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis". Molecular Immunology 124 (2020) 161-171.
10/2020A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
6/2020Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.
3/2020A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis.
1/2020Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
4/2019Leishmania infantum β-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis.
1/2019Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fernanda F Ramos Research Topics

Disease

41Visceral Leishmaniasis (Kala Azar)
06/2022 - 01/2016
20Infections
06/2022 - 11/2017
20Leishmaniasis
06/2022 - 01/2016
4Chagas Disease (American Trypanosomiasis)
12/2021 - 01/2016
4Coinfection
12/2021 - 01/2020
2HIV Infections (HIV Infection)
12/2021 - 11/2021
2Neglected Diseases
06/2020 - 01/2020
1Drug-Related Side Effects and Adverse Reactions
02/2022
1COVID-19
01/2022
1Leprosy (Hansen's Disease)
12/2021
1Paracoccidioidomycosis (South American Blastomycosis)
12/2021
1Tuberculosis (Tuberculoses)
12/2021
1Parasitic Diseases (Parasitic Disease)
02/2021
1Heart Diseases (Heart Disease)
01/2021
1Necrosis
01/2019
1Disease Progression
01/2018
1Ehrlichiosis
08/2017
1Babesiosis (Piroplasmosis)
08/2017

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
06/2022 - 08/2017
14VaccinesIBA
06/2022 - 09/2017
11AntibodiesIBA
01/2022 - 01/2016
11AntigensIBA
12/2021 - 08/2017
10Recombinant ProteinsIBA
06/2022 - 01/2019
7B-Lymphocyte Epitopes (B-Cell Epitope)IBA
06/2022 - 01/2019
5Peptides (Polypeptides)IBA
12/2021 - 09/2017
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2021 - 01/2018
5Immunoglobulin G (IgG)IBA
02/2021 - 01/2016
4Interleukin-12 (IL 12)IBA
02/2021 - 10/2018
3Recombinant Fusion ProteinsIBA
12/2021 - 10/2018
3Pyridoxal KinaseIBA
12/2020 - 01/2020
3T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
06/2020 - 10/2018
3ProhibitinsIBA
01/2020 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2018
3Interleukin-4 (Interleukin 4)IBA
01/2019 - 01/2018
3Interleukin-10 (Interleukin 10)IBA
01/2019 - 01/2018
2MicellesIBA
01/2022 - 01/2020
2N 30IBA
12/2021 - 01/2016
2Virulence Factors (Pathogenicity Factors)IBA
02/2021 - 01/2018
2A-Form DNA (A-DNA)IBA
02/2021 - 01/2019
2CardenolidesIBA
01/2021 - 01/2021
2DNA VaccinesIBA
12/2020 - 01/2020
2Synthetic Vaccines (Recombinant Vaccines)IBA
06/2020 - 01/2020
2NitritesIBA
01/2020 - 01/2018
2InterferonsIBA
10/2018 - 01/2018
1EnzymesIBA
06/2022
1ImmunosorbentsIBA
06/2022
1NaphthoquinonesIBA
02/2022
1Poloxamer (Poloxamer 407)IBA
01/2022
1Guanosine Triphosphate (GTP)IBA
01/2022
1GTP-Binding Proteins (G-Protein)IBA
01/2022
1EpitopesIBA
11/2021
1SaponinsIBA
02/2021
1Ivermectin (Mectizan)FDA Link
02/2021
1Pharmaceutical PreparationsIBA
02/2021
1DigitoxigeninIBA
01/2021
1Therapeutic UsesIBA
01/2021
1DigitoxinFDA Link
01/2021
1miltefosine (Impavido)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2020
1Liposomes (Liposome)IBA
06/2020
1Peptide Initiation Factors (Initiation Factor)IBA
01/2020
1Leishmania infantum amastin proteinIBA
01/2020
1UCON 50-HB-5100 (F127)IBA
01/2020
1Clioquinol (Vioform)FDA Link
01/2020
1Staphylococcal Protein A (Protein A)IBA
12/2019
1Biological ProductsIBA
04/2019
1TubulinIBA
04/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Interleukin-2 (IL2)IBA
01/2019
1CytokinesIBA
12/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018
1InterleukinsIBA
01/2018
1Glutamine (L-Glutamine)FDA Link
11/2017

Therapy/Procedure

1Therapeutics
02/2022
1Aftercare (After-Treatment)
12/2019
1Precision Medicine
04/2019
1Drug Therapy (Chemotherapy)
01/2018